Long-COVID and Cardiovascular Sequelae
Since the start of the pandemic in 2020, Baylor College of Medicine has been a leader in vaccine research, testing and therapeutic discovery, and in providing expert healthcare to patients suffering from COVID and its long-term health effects. In March 2021, Baylor Medicine opened the Post-COVID Care Clinic, a dedicated clinic to provide care to patients experiencing long-term impacts of COVID-19. Long-term symptoms of COVID-19 can affect several organ systems in the body, but the most concerning are those that affect the lungs, heart, and brain.
The Post-COVID Forum is an event to invite all faculty involved in the Post-COVID Care Clinic and in COVID research to speak on their experiences and lessons learned. Our goal is to continue to identify pathways to build access to healthcare, define care models for long-COVID patients, and continue research to understand the mechanisms of long-COVID. Baylor College of Medicine has been there through the beginning, middle, and we will be there through the end of the COVID-19 pandemic. We are uniquely positioned in Texas and nationwide to deliver care to people with long-COVID and as a partner in disseminating knowledge to the medical community.
Physicians, Nurse Practitioners, Physician Assistants, Trainees, and Researchers.
At the conclusion of the session, the participants should be able to:
Identify common presentations of post-COVID-19 syndrome.
Describe pathways to diagnosis several common clinical presentations of post-COVID-19 syndrome.
Summarize available therapeutic interventions for post-COVID-19 syndrome.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation